Skin science article

GHK-Cu Dosing Protocol: 50 mg Vial — Collagen & Anti-Aging

GHK-Cu Dosing Protocol: 50 mg Vial — Collagen Synthesis & Anti-Aging Guide GHK-Cu (copper peptide) complete dosing guide for the 50 mg vial — subcutaneous and topical protocols for skin rejuvenation, collagen synthesis, and tissue repair. Quickstart highlights

By Peptide Skincare & Beauty Editorial TeamPublished May 6, 2026

GHK-Cu Dosing Protocol: 50 mg Vial — Collagen Synthesis & Anti-Aging Guide

GHK-Cu (copper peptide) complete dosing guide for the 50 mg vial — subcutaneous and topical protocols for skin rejuvenation, collagen synthesis, and tissue repair.

Quickstart highlights

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine.

Concentration: 5 mg/mL (50 mg vial + 10 mL bacteriostatic water).

At 5 mg/mL: 1 mg = 20 units, 2 mg = 40 units daily.

Blue-green color of reconstituted solution is normal — indicates intact Cu2+ chelation.

GHK-Cu modulates expression of 6,000+ genes; mechanisms include collagen synthesis, SOD induction, and stem cell recruitment.

One 50 mg vial provides 25 daily doses at 2 mg — approximately 3.5 weeks at once-daily dosing.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

1-4

1000

Once daily (SC)

1 mg — 20 units; starting dose; assess skin and systemic response

5-12

2000

2 mg — 40 units; therapeutic dose; one 50 mg vial provides 25 doses at 2 mg

Your free GHK-Cu tracker

Dose reminders

Injection logging

Cycle progress

Reconstitution steps

Draw 10 mL bacteriostatic water (four 2.5 mL draws); inject slowly down the vial wall.

Swirl gently — GHK-Cu dissolves readily due to the copper coordination complex.

Final concentration: 5 mg/mL. At 5 mg/mL: 1 mg = 20 units, 2 mg = 40 units.

Label with date; refrigerate at 2–8 °C. Use within 28 days. Solution will appear slightly blue-green due to the copper chelate — this is normal.

Supplies needed

12-week plan

2 vials

84 syringes

20 mL bac water

84 alcohol swabs

Protocol overview & cycle notes

Stimulate collagen and elastin synthesis, enhance wound healing, activate stem cell recruitment, and provide antioxidant protection through daily GHK-Cu subcutaneous injections, harnessing the tripeptide's 3,000+ gene expression effects.

Cycle length: 12 weeks on.

Off-cycle: 8 weeks off; assess skin, hair, and wound healing improvements before resuming.

Storage & handling

Injection & tracking tips

For skin rejuvenation: inject subcutaneously just beneath the skin in areas of concern (face, neck, décolletage).

For systemic anti-aging effects: inject in the abdomen or outer thigh for general subcutaneous absorption.

Topical use (off-label): dilute reconstituted GHK-Cu to 0.5–1 mg/mL with sterile water and apply directly to skin (avoid eyes).

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

Take standardized facial photographs (same lighting, angle) at baseline, 4 weeks, and 12 weeks to document skin texture and color changes.

Measure wound healing time for minor cuts (time to complete epithelialization) if using for tissue repair.

Track hair diameter and count if using for scalp hair loss; assess at baseline and 12 weeks.

How this works & references

Sources

Source: Pickart L et al. — GHK and molecular mechanisms of skin renewal. Signal Transduct Target Ther. 2017;2:17032

Leyden J et al. — GHK-Cu peptide topical cream: double-blind RCT in facial aging. Cosmetics. 2018

The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Pickart L et al. — Oxid Med Cell Longev — 2012

Frequently asked questions

Related protocols

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

The reference edit

Ingredients, questions
& further reading.

Connected source records selected through this article’s public topic index.

EDITOR’S ABSTRACT

GHK-Cu syringes needles supplies must use polypropylene barrels with synthetic elastomer plungers—natural rubber plungers contain sulfur that chelates copper and inactivates the peptide entirely.
Insulin syringes (1mL volume) matched to actual dose prevent air exposure that oxidizes copper ions, visible as blue-green discoloration that indicates peptide degradation.
Needle gauge for GHK-Cu should be 27–30G for subcutaneous injection—31G increases backpressure that can compromise dose accuracy in small-volume syringes.
Bacteriostatic water maintains the pH 5.5–7.0 range required for copper chelation stability, while normal saline's chloride ions compete for copper coordination and reduce long-term potency by 12% over 28 days.
Glass reconstitution vials with butyl rubber stoppers are chemically inert to copper peptides—polystyrene plastic vials and natural rubber stoppers both cause measurable peptide degradation within 48 hours.
Reconstitution technique requires injecting solvent down the vial wall rather than directly onto powder, then swirling gently without shaking to prevent foam formation that denatures peptides at the air-liquid interface.
Allow alcohol prep pads to fully evaporate (30 seconds minimum) before puncturing vial stoppers—residual isopropyl alcohol dissolves into solution and shifts pH outside the stable range for copper chelation.

Filed from realpeptides.co

Formula cabinet

Ingredients & structured notes

Ingredient index

Can GHK-Cu be used with other active ingredients like Vitamin C or Retinol?

01Yes, GHK-Cu is generally compatible with many other active ingredients. However, we advise applying GHK-Cu first, allowing it to absorb, before applying stronger actives like high-concentration Vitamin C or Retinol. This approach helps minimize pote…

Source · realpeptides.co ⟶

Product index

Related product references

Product

Naruko Ampm 5% B5+GHK-Cu Hydrating Serum

Naruko Ampm 5% B5+GHK-Cu Hydrating Serum Naruko Ampm 5% B5+GHK-Cu Hydrating Serum ingredients explained: Water, Panthenol, Propanediol, Arginine, Phenoxyethanol, Carbomer, Chlorphenesin, PE…

Source: incidecoder.comView reference →

Product

Lovely Southern GHK-Cu Repair Serum

Lovely Southern GHK-Cu Repair Serum Ingredients in Lovely Southern GHK-Cu Repair Serum explained: benefits, concerns, and detailed analysis of 9 ingredients including Water, Sodium Hyaluron…

Source: skinsort.comView reference →

Product

Aseir Custom Auxano Grow Serum A (GHK-Cu)

Aseir Custom Auxano Grow Serum A (GHK-Cu) Ingredients in Aseir Custom Auxano Grow Serum A (GHK-Cu) explained: benefits, concerns, and detailed analysis of 11 ingredients including Aloe Barb…

Source: skinsort.comView reference →

Comparison edit

Read side by side

GHK-Cu Quality Real vs Fake: Spotting the Fakes in 2026

GHK-Cu Quality Real vs Fake: Spotting the Fakes in 2026 Worried about GHK-Cu quality real vs fake? Our 2026 expert guide helps researchers identify pure, effective peptides from dangerous c…

Open comparison ⟶

GHK-Cu versus Matrikine Peptides

Matrikine peptides, including palmitoyl pentapeptide-4 (Matrixyl) and palmitoyl tripeptide-1, represent an alternative class of matrix-stimulating peptides with documented effects on collag…

Comparison of Methods to Minimize GHK-Cu Degradation Reconstituted

Aliquoting Dividing reconstituted solution into single-use portions immediately. Minimizes freeze-thaw cycles and repeated air exposure. Requires extra vials and time; accurate volume measu…

Ask the journal

Related questions

01What If My Arthritis Is Already Advanced — Will GHK-Cu Still Work?

If your imaging shows full-thickness cartilage loss, exposed subchondral bone, or bone-on-bone contact (Kellgren-Lawrence grade 4), GHK-Cu won't regenerate cartilage that no longer exists. The peptide supports the repair capacity of existing chondrocytes. It can't create new cartilage cells where the cellular architecture has been completely eroded. Clinical trials consistently exclude patients with end-stage disease for this reason. The biological substrate required for peptide activity isn't present. That said, GHK-Cu may still reduce inflammatory cytokine levels and provide modest symptom relief even in advanced cases, but structural improvement is unlikely. At that stage, surgical options (joint replacement, osteotomy) address the mechanical problem that biochemical interventions can't resolve.

Source · realpeptides.co ⟶

02What If the Clinical Trial Results Don't Translate to Your Research Model?

Most published trials examining how GHK-Cu studied skin elasticity used human participants aged 45–60 with moderate photoaging. If your research involves younger subjects (<35 years), baseline collagen synthesis rates are already high, making percentage improvements harder to detect. In aged fibroblast cultures (>passage 15), senescence-associated secretory phenotype (SASP) may blunt the peptide's effect. Pretreatment with senolytic agents can restore responsiveness. Animal models present cross-species variability; murine skin has higher baseline MMP activity than human skin, which may exaggerate the peptide's anti-catabolic effect relative to its anabolic function.

Source · realpeptides.co ⟶

03What If My GHK-Cu Serum Turns Blue-Green?

Discard it immediately. Color change indicates copper oxidation and peptide degradation. Copper peptides are chemically unstable in aqueous solution. Oxidized copper forms Cu²⁺ complexes that generate reactive oxygen species, which degrade the GHK backbone and denature the peptide structure. Studies show that oxidized GHK-Cu loses 80% of its MMP-activating capacity within 48 hours of discoloration. Store all copper peptide products at 2–8°C and use within 60 days of opening.

Source · realpeptides.co ⟶

04What If I Need GHK-Cu for Long-Term Studies Spanning 6–12 Months?

Order all peptide at once from a single verified batch and store lyophilized vials at −20°C with desiccant. This maintains copper chelation stability for 18–24 months. Reconstitute only what you need for each experiment and discard unused solution after 72 hours at 4°C, as aqueous GHK-Cu solutions slowly lose copper through oxidation and pH drift even under refrigeration. Avoid freeze-thaw cycles entirely; the osmotic stress during ice crystal formation mechanically disrupts copper coordination bonds. For multi-month studies requiring daily dosing, divide your batch into weekly aliquots immediately upon receipt and never re-freeze a thawed vial.

Source · realpeptides.co ⟶

05What If I Want to Combine GHK-Cu with Retinoids or Chemical Exfoliants?

Continue GHK-Cu injections as scheduled. Systemic peptide administration does not interact with topical retinoids or alpha-hydroxy acids. However, avoid applying topical GHK-Cu formulations on the same evenings you use tretinoin or glycolic acid peels. The low pH environment created by exfoliating acids denatures the copper-peptide complex before it can penetrate even the stratum corneum. Our team has found that patients using both systemic GHK-Cu and prescription tretinoin achieve superior collagen remodelling compared to either intervention alone, likely because retinoids increase fibroblast turnover while GHK-Cu increases procollagen synthesis per cell.

Source · realpeptides.co ⟶

Source shelf

Research & excerpts

Research note

What are the main areas of focus for GHK-Cu clinical trials in 2026?

In 2026, GHK-Cu clinical trials are primarily focusing on skin regeneration, chronic wound healing, and anti-aging applications. Additionally, there's growing interest in its neuroprotective and anti-inflammatory properties for more systemic health benefits. Our team observes a significant diversification in research areas compared to previous years.

Source · realpeptides.co ⟶

Research note

GHK-Cu Studied Androgenetic Alopecia Research — What Works

A 2018 study published in the Journal of Cosmetic Dermatology found that topical GHK-Cu formulations increased hair density by 28% over 12 weeks in androgenetic alopecia patients. Outperforming minoxidil 5% in the same trial cohort. That result didn't come from DHT suppression or vasodilation. It came from copper peptides directly activating tissue remodeling pathways that rebuild follicle stem cell niches. We've spent years reviewing peptide research protocols across hundreds of studies. What separates GHK-Cu studied androgenetic alopecia research from the noise is the mechanism specificity: the compound doesn't just create a better scalp environment for growth. It triggers genetic cascades that reverse miniaturisation at the follicle level. The rest of this piece covers exactly how that works, what the clinical data actually shows, and where the research gaps still exist. What does GHK-Cu studied androgenetic alopecia research reveal about hair regrowth mechanisms? GHK-Cu studied androgenetic alopecia research demonstrates that copper peptides activate TGF-beta and VEGF signaling pathways, which stimulate angiogenesis and extracellular matrix remodeling around miniaturised follicles. Clinical trials show 20–30% increases in hair density over 12–16 weeks when applied topically at 1–5mM concentrations. Unlike DHT blockers, GHK-Cu acts through direct tissue regeneration rather than hormonal suppression. Most people assume hair regrowth compounds work by blocking DHT or dilating blood vessels. That's the finasteride and minoxidil playbook. GHK-Cu studied androgenetic alopecia research reveals a different pathway entirely: copper peptides function as gene expression modulators, upregulating over 70 genes involved in wound healing, collagen synthesis, and stem cell activation while simultaneously downregulating inflammatory and fibrotic pathways. This isn't surface-level scalp health. It's structural follicle repair. This article covers the specific genetic pathways GHK-Cu activates, the clinical trial data behind hair density improvements, and what concentration and delivery methods actually matter for androgenetic alopecia treatment.

Source · realpeptides.co ⟶